In recent years, anthropogenic ecological disruption has escalated tick-borne zoonoses; ticks transmit taxonomically diverse pathogens with overlapping clinical signs, challenging precise diagnosis and increasing risk of simultaneous detection in pooled samples. Despite advancements, current sequencing technologies, such as Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR) assays, and antibody-based detection methods, are hampered by limitations including extended processing times and limited detection throughput. These constraints significantly hinder their effectiveness in high-throughput pathogen screening for animal or patient samples. To address these challenges, we developed an innovative multi-detection method based on the Multi-analyte Suspension Assay (MASA), enabling rapid and accurate diagnosis of a comprehensive panel of 17 vector-borne pathogens. This 17-plex panel comprises Rickettsia spp., Anaplasma phagocytophilum , Borrelia recurrentis , Babesia spp., Borrelia burgdorferi , Rickettsia prowazekii , Rickettsia heilongjiangensis , Orientia tsutsugamushi , Coxiella burnetii , Leptospira , Bartonella spp., Candidatus Ehrlichia erytraense , Hantaan Virus (HTNV), Seoul Virus (SEOV), Crimean-Congo Hemorrhagic Fever Virus (CCHFV), Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV), and Tick-Borne Encephalitis Virus (TBEV). By combining this novel method with traditional techniques, including nested PCR and Real-Time Quantitative Reverse Transcription PCR (qRT-PCR), we achieved accurate detection of pathogens such as Rickettsia spp., Anaplasma phagocytophilum , and SFTSV in tick samples. Notably, the technique revealed the co-existence of multiple pathogens within the same sample group, highlighting its ability in identifying co-detection of pathogens. Additionally, in suspected cases of tick-borne pathogen infection in febrile patients, the method quickly identified positive results for SFTSV and Rickettsia spp. These preliminary results suggest the potential of this method as a promising screening tool for clinical diagnostics, although larger-scale validation is warranted. This method provides a preliminary technical candidate approach for the development of more sensitive field-deployable detection tools.